1
|
Rosário JDS, Moreira FH, Rosa LHF, Guerra W, Silva-Caldeira PP. Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome. Molecules 2023; 28:5921. [PMID: 37570891 PMCID: PMC10421188 DOI: 10.3390/molecules28155921] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2023] [Revised: 08/04/2023] [Accepted: 08/05/2023] [Indexed: 08/13/2023] Open
Abstract
Bismuth-based drugs have been used primarily to treat ulcers caused by Helicobacter pylori and other gastrointestinal ailments. Combined with antibiotics, these drugs also possess synergistic activity, making them ideal for multiple therapy regimens and overcoming bacterial resistance. Compounds based on bismuth have a low cost, are safe for human use, and some of them are also effective against tumoral cells, leishmaniasis, fungi, and viruses. However, these compounds have limited bioavailability in physiological environments. As a result, there is a growing interest in developing new bismuth compounds and approaches to overcome this challenge. Considering the beneficial properties of bismuth and the importance of discovering new drugs, this review focused on the last decade's updates involving bismuth compounds, especially those with potent activity and low toxicity, desirable characteristics for developing new drugs. In addition, bismuth-based compounds with dual activity were also highlighted, as well as their modes of action and structure-activity relationship, among other relevant discoveries. In this way, we hope this review provides a fertile ground for rationalizing new bismuth-based drugs.
Collapse
Affiliation(s)
- Jânia dos Santos Rosário
- Department of Chemistry, Centro Federal de Educação Tecnológica de Minas Gerais, Belo Horizonte 30421-169, MG, Brazil
| | - Fábio Henrique Moreira
- Department of Chemistry, Centro Federal de Educação Tecnológica de Minas Gerais, Belo Horizonte 30421-169, MG, Brazil
| | - Lara Hewilin Fernandes Rosa
- Institute of Chemistry, Universidade Federal de Uberlândia, Campus Santa Mônica, Uberlândia 38400-142, MG, Brazil
| | - Wendell Guerra
- Institute of Chemistry, Universidade Federal de Uberlândia, Campus Santa Mônica, Uberlândia 38400-142, MG, Brazil
| | | |
Collapse
|
2
|
Razmara Z, Delarami HS, Eigner V, Dusek M. Single crystal structure feature and quantum mechanical studies of a new binuclear Bi (III) complex and its activity against Helicobacter pylori. INORG CHEM COMMUN 2022. [DOI: 10.1016/j.inoche.2022.110207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
3
|
Medicinal bismuth: Bismuth-organic frameworks as pharmaceutically privileged compounds. Tetrahedron 2022. [DOI: 10.1016/j.tet.2022.133117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
4
|
Griffith DM, Li H, Werrett MV, Andrews PC, Sun H. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles. Chem Soc Rev 2021; 50:12037-12069. [PMID: 34533144 DOI: 10.1039/d0cs00031k] [Citation(s) in RCA: 64] [Impact Index Per Article: 21.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Bismuth as a relatively non-toxic and inexpensive metal with exceptional properties has numerous biomedical applications. Bismuth-based compounds are used extensively as medicines for the treatment of gastrointestinal disorders including dyspepsia, gastric ulcers and H. pylori infections. Recently, its medicinal application was further extended to potential treatments of viral infection, multidrug resistant microbial infections, cancer and also imaging, drug delivery and biosensing. In this review we have highlighted the unique chemistry and biological chemistry of bismuth-209 as a prelude to sections covering the unique antibacterial activity of bismuth including a description of research undertaken to date to elucidate key molecular mechanisms of action against H. pylori, the development of novel compounds to treat infection from microbes beyond H. pylori and the significant role bismuth compounds can play as resistance breakers. Furthermore we have provided an account of the potential therapeutic application of bismuth-213 in targeted alpha therapy as well as a summary of the biomedical applications of bismuth-based nanoparticles and composites. Ultimately this review aims to provide the state of the art, highlight the untapped biomedical potential of bismuth and encourage original contributions to this exciting and important field.
Collapse
Affiliation(s)
- Darren M Griffith
- Department of Chemistry, Royal College of Surgeons in Ireland, 123 St. Stephens Green, Dublin 2, Ireland.,SSPC, Synthesis and Solid State Pharmaceutical Centre, Ireland
| | - Hongyan Li
- Department of Chemistry and CAS-HKU Joint Laboratory of Metallomics for Health and Environment, The University of Hong Kong, Pokfulam Road, Hong Kong, China.
| | | | - Philip C Andrews
- School of Chemistry, Monash University, Melbourne, VIC, Australia
| | - Hongzhe Sun
- Department of Chemistry and CAS-HKU Joint Laboratory of Metallomics for Health and Environment, The University of Hong Kong, Pokfulam Road, Hong Kong, China.
| |
Collapse
|
5
|
Oliver TE, Piantavigna S, Andrews PC, Holt SA, Dillon CT. Interactions of Non-steroidal Anti-inflammatory Drugs and Their Bismuth Analogues (BiNSAIDs) with Biological Membrane Mimics at Physiological pH. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2021; 37:1337-1352. [PMID: 33478220 DOI: 10.1021/acs.langmuir.0c02212] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Previous studies have demonstrated the potential for non-steroidal anti-inflammatory drugs (NSAIDs), in particular aspirin, to be used as chemopreventives for colorectal cancer; however, a range of unwanted gastrointestinal side effects limit their effectiveness. Due to the role of bismuth in the treatment of gastrointestinal disorders, it is hypothesized that bismuth-coordinated NSAIDs (BiNSAIDs) could be used to combat the gastrointestinal side effects of NSAIDs while still maintaining their chemopreventive potential. To further understand the biological activity of these compounds, the present study examined four NSAIDs, namely, tolfenamic acid (tolfH), aspirin (aspH), indomethacin (indoH), and mefenamic acid (mefH) and their analogous homoleptic BiNSAIDs ([Bi(L)3]n), to determine how these compounds interact with biological membrane mimics composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) or a mixture of POPC and cholesterol. Electrical impedance spectroscopy studies revealed that each of the NSAIDs and BiNSAIDs influenced membrane conductance, suggesting that temporary pore formation may play a key role in the previously observed cytotoxicity of tolfH and Bi(tolf)3. Quartz crystal microbalance with dissipation monitoring showed that all the compounds were able to interact with membrane mimics composed of solely POPC or POPC/cholesterol. Finally, neutron reflectometry studies showed changes in membrane thickness and composition. The location of the compounds within the bilayer could not be determined with certainty; however, a complex interplay of interactions governs the location of small molecules, such as NSAIDs, within lipid membranes. The charged nature of the parent NSAIDs means that interactions with the polar headgroup region are most likely with larger hydrophobic sections, potentially leading to deeper penetration.
Collapse
Affiliation(s)
- Tara E Oliver
- School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales 2522, Australia
- Molecular Horizons, University of Wollongong, Wollongong, New South Wales 2522, Australia
| | - Stefania Piantavigna
- School of Chemistry, Monash University, Clayton, Melbourne, Victoria 3800, Australia
- Australian Centre for Neutron Scattering, Australian Nuclear Science and Technology Organisation, Locked Bag 2001, Kirrawee DC, New South Wales 2232, Australia
| | - Philip C Andrews
- School of Chemistry, Monash University, Clayton, Melbourne, Victoria 3800, Australia
| | - Stephen A Holt
- Australian Centre for Neutron Scattering, Australian Nuclear Science and Technology Organisation, Locked Bag 2001, Kirrawee DC, New South Wales 2232, Australia
| | - Carolyn T Dillon
- School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales 2522, Australia
- Molecular Horizons, University of Wollongong, Wollongong, New South Wales 2522, Australia
| |
Collapse
|
6
|
Kowalik M, Masternak J, Łakomska I, Kazimierczuk K, Zawilak-Pawlik A, Szczepanowski P, Khavryuchenko OV, Barszcz B. Structural Insights into New Bi(III) Coordination Polymers with Pyridine-2,3-Dicarboxylic Acid: Photoluminescence Properties and Anti- Helicobacter pylori Activity. Int J Mol Sci 2020; 21:E8696. [PMID: 33218028 PMCID: PMC7698728 DOI: 10.3390/ijms21228696] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Revised: 11/12/2020] [Accepted: 11/17/2020] [Indexed: 01/19/2023] Open
Abstract
Two novel coordination polymers, [Bi2(2,3pydc)2(2,3pydcH)2(H2O)]n (1) and {(Et3NH)2[Bi(2,3pydc)(2,3pydcH)Cl2]}n (2) were prepared using as a prolinker pyridine-2,3-dicarboxylic acid (2,3pydcH2). The obtained complexes were fully characterized by elemental analysis, TG/DTG, FT-IR, solid-state photoluminescence, DFT calculations and single-crystal X-ray diffraction. The obtained complexes crystallized in the triclinic P-1 space group (1) and comprise dimeric units with two crystallographically different Bi(III) centers (polyhedra: distorted pentagonal bipyramid and bicapped trigonal prism) and monoclinic P21/c space group (2) with a distorted monocapped pentagonal bipyramid of Bi(III) center. The various coordination modes of bridging carboxylate ligands are responsible for the formation of 1D chains with 4,5C10 (1) and 2C1 (2) topology. The photoluminescence quantum yield for polymer 2 is 8.36%, which makes it a good candidate for more specific studies towards Bi-based fluorescent materials. Moreover, it was detected that polymer 1 is more than twice as active against H. pylori as polymer 2. It can be concluded that there is an existing relationship between the structure and the antibacterial activity because the presence of chloride and triethylammonium ions in the structure of complex 2 reduces the antibacterial activity.
Collapse
Affiliation(s)
- Mateusz Kowalik
- Institute of Chemistry, Jan Kochanowski University in Kielce, Uniwersytecka 7, 25-406 Kielce, Poland; (J.M.); (B.B.)
| | - Joanna Masternak
- Institute of Chemistry, Jan Kochanowski University in Kielce, Uniwersytecka 7, 25-406 Kielce, Poland; (J.M.); (B.B.)
| | - Iwona Łakomska
- Faculty of Chemistry, Nicolaus Copernicus University in Toruń, Gagarina 7, 87-100 Toruń, Poland
| | - Katarzyna Kazimierczuk
- Department of Inorganic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, G. Narutowicza 11/12, 80-233 Gdańsk, Poland;
| | - Anna Zawilak-Pawlik
- Laboratory of Molecular Biology of Microorganisms, Microbiology Department, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wrocław, Poland; (A.Z.-P.); (P.S.)
| | - Piotr Szczepanowski
- Laboratory of Molecular Biology of Microorganisms, Microbiology Department, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wrocław, Poland; (A.Z.-P.); (P.S.)
| | - Oleksiy V. Khavryuchenko
- Shupyk National Medical Academy of Postgraduate Education (NMAPE), Dorogozhytska 9, 04112 Kyiv, Ukraine;
| | - Barbara Barszcz
- Institute of Chemistry, Jan Kochanowski University in Kielce, Uniwersytecka 7, 25-406 Kielce, Poland; (J.M.); (B.B.)
| |
Collapse
|
7
|
Wang R, Li H, Ip TKY, Sun H. Bismuth drugs as antimicrobial agents. Med Chem 2020. [DOI: 10.1016/bs.adioch.2019.10.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
8
|
Andleeb S, Imtiaz-ud-Din. Recent progress in designing the synthetic strategies for bismuth based complexes. J Organomet Chem 2019. [DOI: 10.1016/j.jorganchem.2019.120871] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
9
|
Kowalski K. Insight into the Biological Activity of Organometallic Acetylsalicylic Acid (Aspirin) Derivatives. Chempluschem 2019; 84:403-415. [DOI: 10.1002/cplu.201900086] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2019] [Revised: 03/27/2019] [Indexed: 01/04/2023]
Affiliation(s)
- Konrad Kowalski
- Faculty of Chemistry Department of Organic ChemistryUniversity of Łódź Tamka 12 91-403 Łódź Poland
| |
Collapse
|
10
|
Ouerghi Z, Gornitzka H, Temel E, Dridi I, Kefi R. A new non-centrosymmetric Chlorobismuthate(III) hybrid material: Crystal structure, optical properties and antibacterial study. J Mol Struct 2019. [DOI: 10.1016/j.molstruc.2018.12.108] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
11
|
Vilela SMF, Devic T, Várez A, Salles F, Horcajada P. A new proton-conducting Bi-carboxylate framework. Dalton Trans 2019; 48:11181-11185. [DOI: 10.1039/c9dt02009h] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
A new robust Bi-carboxylate metal–organic framework (MOF) IEF-2 was hydrothermally prepared, acting as a proton carrier (σ ∼ 1.1 × 10−4 S cm−1).
Collapse
Affiliation(s)
- Sérgio M. F. Vilela
- Advanced Porous Materials Unit (APMU)
- IMDEA Energy Institute
- E-28938 Móstoles
- Spain
| | - Thomas Devic
- Institut des Matériaux Jean Rouxel (IMN) CNRS UMR 6502
- Université de Nantes
- Nantes Cedex 3
- France
| | - Alejandro Várez
- Department of Materials Science and Engineering and Chemical Engineering
- Universidad Carlos III de Madrid
- E-28911 Leganés
- Spain
| | - Fabrice Salles
- Institut Charles Gerhardt de Montpellier (ICGM) UMR 5253 CNRS-UM-ENSCM
- 34095 Montpellier Cedex 05
- France
| | - Patricia Horcajada
- Advanced Porous Materials Unit (APMU)
- IMDEA Energy Institute
- E-28938 Móstoles
- Spain
| |
Collapse
|
12
|
Wrobel L, Rüffer T, Korb M, Krautscheid H, Meyer J, Andrews PC, Lang H, Mehring M. Homo- and Heteroleptic Coordination Polymers and Oxido Clusters of Bismuth(III) Vinylsulfonates. Chemistry 2018; 24:16630-16644. [DOI: 10.1002/chem.201803664] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Indexed: 11/12/2022]
Affiliation(s)
- Lydia Wrobel
- Fakultät für Naturwissenschaften, Institut für Chemie, Professur Koordinationschemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| | - Tobias Rüffer
- Fakultät für Naturwissenschaften, Institut für Chemie, Professur Anorganische Chemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| | - Marcus Korb
- Fakultät für Naturwissenschaften, Institut für Chemie, Professur Anorganische Chemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| | - Harald Krautscheid
- Fakultät für Chemie und Mineralogie, Institut für Anorganische Chemie; Universität Leipzig; 04103 Leipzig Germany
| | - Jens Meyer
- STOE & Cie GmbH; 64295 Darmstadt Germany
| | - Philip C. Andrews
- School of Chemistry; Monash University; Melbourne Victoria 3800 Australia
| | - Heinrich Lang
- Fakultät für Naturwissenschaften, Institut für Chemie, Professur Anorganische Chemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| | - Michael Mehring
- Fakultät für Naturwissenschaften, Institut für Chemie, Professur Koordinationschemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| |
Collapse
|
13
|
Abstract
Bismuth salts exert their activity within the upper gastrointestinal tract through action of luminal bismuth. Bismuth exerts direct bactericidal effect on Helicobacter pylori by different ways: forms complexes in the bacterial wall and periplasmic space, inhibits different enzymes, ATP synthesis, and adherence of the bacteria to the gastric mucosa. Bismuth also helps ulcer healing by acting as a barrier to the aggressive factors and increasing mucosal protective factors such as prostaglandin, epidermal growth factor, and bicarbonate secretion. To date, no resistance to bismuth has been reported. Also synergism between bismuth salts and antibiotics was present. It was shown that metronidazole and clarithromycin resistant H. pylori strains become susceptible if they are administered together with bismuth. Bismuth-containing quadruple therapy was recommended both by the Second Asia-Pacific Consensus Guidelines and by the Maastricht IV/Florence Consensus Report as an alternative first choice regimen to standard triple therapy, in areas with low clarithromycin resistance, and it is recommended as the first-line therapeutic option in areas with a high prevalence of clarithromycin resistance. Greater than 90% eradication success can be obtained by bismuth-containing quadruple therapy. Choosing bismuth as an indispensable part of first-line therapy is logical as both metronidazole and clarithromycin resistances can be overcome by adding bismuth to the regimen.
Collapse
|
14
|
Vilela SMF, Babaryk AA, Jaballi R, Salles F, Mosquera MEG, Elaoud Z, Van Cleuvenbergen S, Verbiest T, Horcajada P. A Nonlinear Optically Active Bismuth–Camphorate Coordination Polymer. Eur J Inorg Chem 2018. [DOI: 10.1002/ejic.201800197] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Sérgio M. F. Vilela
- Advanced Porous Materials Unit (APMU) IMDEA Energy Avda. Ramón de la Sagra 3 E‐28938 Móstoles, Madrid Spain
| | - Artem A. Babaryk
- Advanced Porous Materials Unit (APMU) IMDEA Energy Avda. Ramón de la Sagra 3 E‐28938 Móstoles, Madrid Spain
| | - Rim Jaballi
- Laboratory of Physical‐Chemistry of Solid State University of Sfax Faculty of Science of Sfax University of Sfax Sfax Tunisia
| | - Fabrice Salles
- Institut Charles Gerhardt de Montpellier, UMR 5253 CNRS‐UM‐ENSCM Faculty of Science of Sfax Université de Montpellier Montpellier Cedex 05 France
| | - Marta E. G. Mosquera
- Departamento de Química Orgánica y Química Inorgánica Faculty of Science of Sfax Universidad de Alcalá 28871 Alcalá de Henares Spain
| | - Zakaria Elaoud
- Laboratory of Physical‐Chemistry of Solid State University of Sfax Faculty of Science of Sfax University of Sfax Sfax Tunisia
| | - Stijn Van Cleuvenbergen
- Molecular Imaging and Photonics Department of Chemistry KU Leuven Celestijnenlaan 200D 3001 Heverlee Belgium
| | - Thierry Verbiest
- Molecular Imaging and Photonics Department of Chemistry KU Leuven Celestijnenlaan 200D 3001 Heverlee Belgium
| | - Patricia Horcajada
- Advanced Porous Materials Unit (APMU) IMDEA Energy Avda. Ramón de la Sagra 3 E‐28938 Móstoles, Madrid Spain
| |
Collapse
|
15
|
Pathak A, Blair VL, Ferrero RL, Kedzierski L, Andrews PC. Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania. J Inorg Biochem 2017; 177:266-275. [PMID: 28583712 DOI: 10.1016/j.jinorgbio.2017.05.014] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2017] [Revised: 05/29/2017] [Accepted: 05/30/2017] [Indexed: 12/21/2022]
Abstract
Seven new bismuth(III) complexes derived from indole-carboxylic acids have been synthesised: five are homoleptic; [Bi(IAA)3] B1, [Bi(IPA)3] B2, [Bi(IBA)3] B3, [Bi(MICA)3] B4, [Bi(IGA)3] B6, and two are heteroleptic [BiPh(MICA)2] B5 (where IAA-H=2-(1H-indol-3-yl)acetic acid, IPA-H=3-(1H-indol-3-yl)propanoic acid, IBA-H=4-(1H-indol-3-yl)butanoic acid, IGA-H=2-(1H-indol-3-yl)-2-oxoacetic acid, and MICA-H=1-methyl-1H-indole-3-carboxylic acid). All complexes were fully characterised by elemental analysis, infrared and mass-spectroscopy, and nuclear magnetic resonance (1H, 13C) spectroscopy. Complex [BiPh(IGA)2] B7 is structurally authenticated by X-ray crystallography as a dimer in the solid-state. The in-vitro anti-bacterial activity of the indole-carboxylic acids and their bismuth(III) complexes was assessed against Helicobacter pylori. While the acids were non-toxic at <100μgmL-1, all the bismuth compounds showed an MIC of 6.25μgmL-1, indicating that the anti-bacterial activity is insensitive to the degree of substitution at the Bi(III) centre or the composition of the indole-carboxylate ligands. All compounds were further tested for their anti-parasitic activity against Leishmania major and for their toxicity towards mammalian cells. From the anti-parasitic studies, it was found that the heteroleptic bismuth(III) complexes are the most active, with B5 and B7 showing comparable activity to Amphotericin B, without any toxicity towards the mammalian cells at their effective concentration.
Collapse
Affiliation(s)
- Amita Pathak
- School of Chemistry, Monash University, Clayton, Melbourne, VIC 3800, Australia
| | - Victoria L Blair
- School of Chemistry, Monash University, Clayton, Melbourne, VIC 3800, Australia
| | - Richard L Ferrero
- Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Melbourne, VIC 3168, Australia
| | - Lukasz Kedzierski
- Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville 3010, Australia
| | - Philip C Andrews
- School of Chemistry, Monash University, Clayton, Melbourne, VIC 3800, Australia.
| |
Collapse
|
16
|
Wrobel L, Rüffer T, Korb M, Lang H, Mehring M. Bismuth(III) Anthranilates - Synthesis and Characterization of a Coordination Polymer and a Polynuclear Oxido Cluster. Eur J Inorg Chem 2017. [DOI: 10.1002/ejic.201601426] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Lydia Wrobel
- Fakultät für Naturwissenschaften; Institut für Chemie, Professur Koordinationschemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| | - Tobias Rüffer
- Fakultät für Naturwissenschaften; Institut für Chemie, Professur Anorganische Chemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| | - Marcus Korb
- Fakultät für Naturwissenschaften; Institut für Chemie, Professur Anorganische Chemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| | - Heinrich Lang
- Fakultät für Naturwissenschaften; Institut für Chemie, Professur Anorganische Chemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| | - Michael Mehring
- Fakultät für Naturwissenschaften; Institut für Chemie, Professur Koordinationschemie; Technische Universität Chemnitz; 09107 Chemnitz Germany
| |
Collapse
|
17
|
Keogan DM, Twamley B, Fitzgerald-Hughes D, Griffith DM. Novel class of Bi(iii) hydroxamato complexes: synthesis, urease inhibitory activity and activity against H. pylori. Dalton Trans 2016; 45:11008-14. [DOI: 10.1039/c5dt05061h] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
A novel class of bismuth hydroxamato complexes of type Bi(L-1H)2·NO3 (where L is hydroxamic acid) were specifically designed to and demonstrated to inhibit urease, H. pylori's Achilles heel.
Collapse
Affiliation(s)
- D. M. Keogan
- Centre for Synthesis & Chemical Biology
- Department of Pharmaceutical & Medicinal Chemistry
- Royal College of Surgeons in Ireland
- Dublin 2
- Ireland
| | - B. Twamley
- School of Chemistry
- Chemistry Building
- Trinity College Dublin
- Dublin 2
- Ireland
| | - D. Fitzgerald-Hughes
- RCSI Microbiology
- Royal College of Surgeons in Ireland
- RCSI Education & Research Centre
- Beaumont Hospital
- Dublin 9
| | - D. M. Griffith
- Centre for Synthesis & Chemical Biology
- Department of Pharmaceutical & Medicinal Chemistry
- Royal College of Surgeons in Ireland
- Dublin 2
- Ireland
| |
Collapse
|
18
|
Three new bismuth(III) pyridine-2,6-dicarboxylate compounds: Synthesis, characterization and crystal structures. J Mol Struct 2015. [DOI: 10.1016/j.molstruc.2015.06.084] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
19
|
Influence of pH and type of counterion on the formation of bismuth(III) complexes with tropolonato and 5-methyltropolonato ligands: Synthesis, structure, spectroscopic characterization and calculation studies. Inorganica Chim Acta 2015. [DOI: 10.1016/j.ica.2015.07.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
20
|
Keogan DM, Griffith DM. Current and potential applications of bismuth-based drugs. Molecules 2014; 19:15258-97. [PMID: 25251194 PMCID: PMC6271281 DOI: 10.3390/molecules190915258] [Citation(s) in RCA: 104] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2014] [Revised: 09/04/2014] [Accepted: 09/04/2014] [Indexed: 02/06/2023] Open
Abstract
: Bismuth compounds have been used extensively as medicines and in particular for the treatment of gastrointestinal ailments. In addition to bismuth's well known gastroprotective effects and efficacy in treating H. pylori infection it also has broad anti-microbial, anti-leishmanial and anti-cancer properties. Aspects of the biological chemistry of bismuth are discussed and biomolecular targets associated with bismuth treatment are highlighted. This review strives to provide the reader with an up to date account of bismuth-based drugs currently used to treat patients and discuss potential medicinal applications of bismuth drugs with reference to recent developments in the literature. Ultimately this review aims to encourage original contributions to this exciting and important field.
Collapse
Affiliation(s)
- Donal M Keogan
- Centre for Synthesis & Chemical Biology, Department of Pharmaceutical & Medicinal Chemistry, Royal College of Surgeons in Ireland, 123 St. Stephens Green, Dublin 2, Ireland
| | - Darren M Griffith
- Centre for Synthesis & Chemical Biology, Department of Pharmaceutical & Medicinal Chemistry, Royal College of Surgeons in Ireland, 123 St. Stephens Green, Dublin 2, Ireland.
| |
Collapse
|
21
|
Tröbs L, Wilke M, Szczerba W, Reinholz U, Emmerling F. Mechanochemical synthesis and characterisation of two new bismuth metal organic frameworks. CrystEngComm 2014. [DOI: 10.1039/c3ce42633e] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Two metal organic structures composed of the ligands benzene-1,4-dicarboxylate and pyridine-2,5-dicarboxylate and bismuth cations are presented: (H2Im)[Bi(1,4-bdc)2] (1) and [Bi(pydc)(NO3)2(H2O)2]·H2O (2) (bdc = benzenedicarboxylate, H2Im = imidazole cation, pydc = pyridinedicarboxylate).
Collapse
Affiliation(s)
- L. Tröbs
- BAM Federal Institute for Materials Research and Testing
- 12489 Berlin, Germany
| | - M. Wilke
- BAM Federal Institute for Materials Research and Testing
- 12489 Berlin, Germany
| | - W. Szczerba
- BAM Federal Institute for Materials Research and Testing
- 12489 Berlin, Germany
| | - U. Reinholz
- BAM Federal Institute for Materials Research and Testing
- 12489 Berlin, Germany
| | - F. Emmerling
- BAM Federal Institute for Materials Research and Testing
- 12489 Berlin, Germany
| |
Collapse
|